---
$id: https://graph.org.ai/products/commodity/51141518
$type: Product
source: UNSPSC
code: "51141518"
title: "Levetiracetam"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levetiracetam

**UNSPSC Code**: 51141518
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent and anticonvulsant agent with the molecular formula C8H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 44YRR34555, chemically known as 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-, (s)- but generally known as levetiracetam, which bears US NIH Compound Identifier 59708. European Medicines Agency schedules Levetiracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08459MIG. The term LEVETIRACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules levetiracetam in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule levetiracetam under HS 29337900 and SITC 51561. As of Q4 2014, LEVETIRACETAM remains the US FDA Preferred Term for this commodity. Levetiracetam bears US NLM identifiers UMLS ID C0377265 and NCI Concept Code C47581. SMILES: O=C1N(CCC1)C(CC)C(=O)N.

